June 2015

academics

 

Clinical research courses

30 June 2015

Jubilant Life Sciences' receives ANDA approval for levofloxacin tablets

Jubilant Life Sciences Ltd, an integrated global pharmaceuticals and life sciences company, has received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (US FDA) for levofloxacin tablets, 250mg and 500mg. It is used for the treatment of adults with infections such as pneumonia, bacterial sinusitis, chronic bronchitis, skin and skin structure infections, chronic bacterial prostatitis, urinary tract infections and inhalational anthrax.

29 June 2015
Career as Senior Clinical Process Specialist in Quintiles

Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. Our network of 23,000 engaged professionals in 60 countries around the globe works with an unwavering commitment to patients, safety and ethics — ensuring a higher level of healthcare for people. For our biopharmaceutical customers, we help them navigate risk and seize opportunities in an environment where change is constant.
Quintiles is consistently cited as the most favored contract research organization (CRO) in independent surveys of the bio pharma industry and was recently named “2009 CRO of the Year” by the prestigious SCRIP Awards.

Post: Sr. Clinical Process Specialist-1512201

29 June 2015
Required for Manager, Quality Assurance in Nektar

Nektar Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to improve the benefits of drugs for patients. Its product pipeline consists of drug candidates across a number of therapeutic areas, including oncology, pain, anti-infectives, anti-viral and immunology. Nektar's research and development activities involve small molecule drugs, peptides and other potential biologic drug candidates. Its drug candidates are designed to improve the pharmacokinetics, pharmacodynamics, half-life, bioavailability, metabolism or distribution of drugs and improve the overall benefits and use of a drug for the patient.

Post: Manager, Quality Assurance (India)

29 June 2015
Work as Senior Manager, Reg Affairs in Baxter

Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter had 2012 sales of $14.2 billion and has approximately 50,800 employees.

Post: Senior Manager, Reg Affairs-150005UK

Wockhardt has received final approval from the US FDA for marketing 5mg/5ml of oxycodone HCI liquid. The company is launching the product soon and will be amongst the few generic versions of this product in the market.

Researchers from the Laboratory of Cancer Metabolism at IDIBELL found a potential target for the treatment of type 2 diabetes. The study is published in the Journal of Clinical Investigation. Research led by Sara Kozma, have shown in animal models that inhibition of S6K1 protein may be a potential treatment for type 2 diabetes.

Nearly 700,000 people around the world die from colorectal cancer each year. Colorectal cancer is the second leading cause of cancer-related death in developed countries.  Anti-cancer therapies generally involve killing off tumor cells. A new study says, now the cancer cells can be turned back into normal tissue simply by reactivating a single gene.  The study is published in the Cell.

(adsbygoogle = window.adsbygoogle || []).push({});

Aurobindo Pharma got final approvals from the US FDA of azithromycin for injection USP, 500mg /vial and entacapone tablets. Azithromycin for injection USP, 500mg/vial is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Zithromax (azithromycin for injection) 500mg/vial of Pfizer, Inc. Azithromycin for injection, USP is a macrolide antibacterial drug indicated for the treatment of patients with infections caused by susceptible strains of the designated microorganisms in the conditions such as community-acquired pneumonia and pelvic inflammatory disease.

Australian researchers have developed a breakthrough vaccine-style therapeutic approach to treat rheumatoid arthritis, a debilitating disease affecting over 450,000 people in the country. Lead researcher Ranjeny Thomas from the University of Queensland's Diamantina Institute said results from the phase one clinical trial demonstrate the new treatment is safe and effective in supressing the immune response.

28 June 2015
Detailed info. on Pharmacists (36 posts) vacancies at Border Security Force

Applications are invited from male & female Indian citizens for appointment of following posts (Group 'B' & 'C' Combatised) for Para Medical Staff in the Border Security Force, Ministry of Home Affairs, Government of India. The post is temporary but likely to become permanent.

Post: ASI (Pharmacist- Qualified) (Group-C Post)

Subscribe with us




 


 

 

Do Not Forget to Verify

(Click on Subscription link in your inbox)

--------

whatsapp

 

Also Join:  youtube  telegram

Clini India

 

PC-ISIT

Jobs by Category

Production Jobs

R&D Jobs

F&D Jobs

Sales & Marketing

QA Jobs

QC Jobs

Faculty Jobs

CRO Jobs

DRA Jobs

IPR Jobs

IT Jobs

Packaging Alerts

Hospital Pharmacist